Metabolic Impairment in Coronary Artery Disease: Elevated Serum Acylcarnitines Under the Spotlights

Coronary artery disease (CAD) remains the leading cause of death worldwide. Expanding patients' metabolic phenotyping beyond clinical chemistry investigations could lead to earlier recognition of disease onset and better prevention strategies. Additionally, metabolic phenotyping, at the molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Gander, Joséphine, Carrard, Justin, Gallart-Ayala, Hector, Borreggine, Rébecca, Teav, Tony, Infanger, Denis, Colledge, Flora, Streese, Lukas, Wagner, Jonathan, Klenk, Christopher, Nève, Gilles, Knaier, Raphael, Hanssen, Henner, Schmidt-Trucksäss, Arno, Ivanisevic, Julijana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716394/
https://www.ncbi.nlm.nih.gov/pubmed/34977199
http://dx.doi.org/10.3389/fcvm.2021.792350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716394/
https://www.ncbi.nlm.nih.gov/pubmed/34977199
http://dx.doi.org/10.3389/fcvm.2021.792350

Ejemplares similares